pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
131
view
list
cards
Marketed
standardized mite (Dermatophagoides pteronyssinus + Dermatophagoides farinae) allergen extract
Odactra
Allergic Rhino-Conjunctivitis
ALK-Abello Inc
Marketed
standardized short ragweed pollen (Ambrosia artemisiifolia) allergen extract
Short Ragweed Pollen Allergenic Extract
Allergic Rhinitis
Jubilant HollisterStier LLC
Marketed
streptomycin sulfate
Streptomycin Sulfate
Bacteremia
X-GEN Pharmaceuticals DJB Inc
← prev
page 219 of 231
next →
Pain
89
Neurology
1
Marketed
succimer
Chemet (succimer)
Lead Poisoning
Recordati Rare Diseases Inc
Marketed
succinylcholine chloride
Succinylcholine Chloride
General Anesthetic Effect
Nordic Pharma Inc
Marketed
sugammadex sodium
Sugammadex Sodium
Anesthetic Effect
B. Braun Medical Inc
Phase 2
sugemalimab
Cejemly (sugemalimab [INN])
Natural Killer Cell Lymphomas
CStone Pharmaceuticals Co Ltd
Marketed
sulconazole nitrate
Exelderm (sulconazole nitrate)
Tinea Corporis
$DERM
Journey Medical Corp
Marketed
sulfadiazine
Sulfadiazine
Otitis Media
Epic Pharma LLC
Marketed
sulfisoxazole
Sulfisoxazole
Bacterial (Pyogenic) Meningitis
Roxane Laboratories Inc
Marketed
sulindac
Sulindac
Acute and Sub-Acute Bursitis
Epic Pharma LLC
Marketed
sumatriptan
Sumatriptan (sumatriptan [INN])
Migraine
Florida Pharmaceutical Products LLC
pre_registration
sumecigrel
sumecigrel
Acute Coronary Syndrome
Jiangsu Vcare PharmaTech Co Ltd
Marketed
sunitinib malate
Sunitinib Malate
Gastrointestinal Stromal Tumor (GIST)
Wanbang Biopharmaceuticals Co Ltd
Phase 2
sunobinop tosylate
sunobinop tosylate
Alcohol Use Disorder (AUD)
Imbrium Therapeutics LP
Marketed
sunvozertinib
Zegfrovy (sunvozertinib)
Non-Small Cell Lung Cancer
Dizal Pharmaceutical Co Ltd
Phase 3
surabgene lomparvovec
surabgene lomparvovec
Wet (Neovascular / Exudative) Macular Degeneration
$ABBV
AbbVie Inc.
Phase 2
suratadenoturev
Telomelysin (suratadenoturev)
Adenocarcinoma Of The Gastroesophageal Junction
Oncolys BioPharma Inc
Phase 1
surlorian fumarate
surlorian fumarate
Unspecified Musculoskeletal Disorders
RyCarma Therapeutics Inc
Phase 2
surovatamig
surovatamig [INN]
B-Cell Non-Hodgkin Lymphoma
$AZN
ASTRAZENECA PLC
Phase 2
surufatinib
surufatinib
Solid Tumor
$HCM
HUTCHMED (China) Ltd
Phase 3
survodutide
survodutide
Liver Fibrosis
Boehringer Ingelheim International GmbH
Phase 2
surzebiclimab
surzebiclimab
Recurrent Head And Neck Squamous Cell Carcinoma
$ONC
BeOne Medicines Ltd.
Phase 2
sutacimig
sutacimig [INN]
Bleeding And Clotting Disorders
Hemab ApS
Marketed
sutimlimab
Enjaymo (sutimlimab-jome)
Acquired (Autoimmune) Hemolytic Anemia
Bioverativ Inc
Marketed
suvorexant
Belsomra (suvorexant)
Insomnia
$MRK
Merck & Co., Inc.
Phase 2
suvratoxumab
suvratoxumab
Staphylococcus aureus Infections
Aridis Pharmaceuticals Inc
Phase 3
tadekinig alfa
tadekinig alfa [INN]
Hemophagocytic Lymphohistiocytosis
AB2 Bio Ltd
Marketed
tafamidis
Vyndamax (tafamidis)
Familial Amyloid Cardiomyopathy
$PFE
PFIZER INC
Phase 3
tafasitamab
Monjuvi (tafasitamab)
Extranodal Marginal Zone B-Cell Lymphoma (Mucosa-Associat…
$INCY
INCYTE CORP